NVO
Novo Nordisk A S
$49.48
+0.60 (+1.23%)
At close · Jul 10
Market Cap
$218.94B
Shares
3,349,933,520
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-07-06 | — | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-24 | 2026-06-22 | |
| 6-K | 2026-06-15 | — | |
| 6-K | 2026-06-08 | — | |
| 6-K | 2026-06-01 | — | |
| 6-K | 2026-05-27 | 2026-05-26 | |
| 6-K | 2026-05-22 | — | |
| 6-K | 2026-05-22 | — | |
| 6-K | 2026-05-18 | — | |
| 6-K | 2026-05-13 | 2026-05-12 | |
| 6-K | 2026-05-06 | 2026-03-31 | |
| 6-K | 2026-05-05 | — | |
| 6-K | 2026-04-27 | — | |
| 6-K | 2026-04-20 | — | |
| 6-K | 2026-04-20 | — | |
| 6-K | 2026-04-13 | — | |
| 6-K | 2026-04-07 | — | |
| 6-K | 2026-03-30 | — | |
| 6-K | 2026-03-27 | — | |
| 6-K | 2026-03-27 | — | |
| 6-K | 2026-03-26 | — | |
| 6-K | 2026-03-23 | — | |
| 6-K | 2026-03-20 | 2026-03-19 | |
| 6-K | 2026-03-17 | 2026-03-16 | |
| 6-K | 2026-03-09 | — | |
| 6-K | 2026-03-02 | — | |
| 6-K | 2026-03-02 | — | |
| 6-K | 2026-02-23 | — | |
| 6-K | 2026-02-23 | — | |
| 6-K | 2026-02-20 | — | |
| 6-K | 2026-02-17 | 2026-02-16 | |
| 6-K | 2026-02-11 | — | |
| 6-K | 2026-02-10 | — | |
| 6-K | 2026-02-09 | — | |
| 6-K | 2026-02-05 | 2026-02-04 | |
| 6-K | 2026-02-05 | 2026-02-04 | |
| 6-K | 2026-02-05 | — | |
| 6-K | 2026-02-04 | 2025-12-31 | |
| 20-F | 2026-02-04 | 2025-12-31 | |
| 6-K | 2026-02-03 | 2025-12-31 | |
| 6-K | 2026-02-03 | — | |
| 6-K | 2026-02-02 | 2026-01-31 | |
| 6-K | 2026-02-02 | — | |
| 6-K | 2025-12-23 | 2025-12-22 | |
| 6-K | 2025-11-25 | — | |
| 6-K | 2025-11-24 | — | |
| 6-K | 2025-11-17 | — | |
| 6-K | 2025-11-14 | 2025-11-13 | |
| 6-K | 2025-11-14 | — |
Showing 1–50 of 539 filings
Key facts
CIK
353278
CUSIP
670100205
13F (30d)
90 filings
89 filers
Visit website
Investor relations